TrialFrontiers in endocrinology2022

A Novel Inflammation and Insulin Resistance Related Indicator to Predict the Survival of Patients With Cancer.

Guo-Tian Ruan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.